US Patent Eligibility in the Wake of Bilski v Kappos: "Business as Usual" in an Age of New Technologies?
THIS ARTICLE DISCUSSES the recent US Supreme Court decision in Bilski v Kappos. Although specifically applicable to the patentability of business methods, this seminal decision has consequences for determining patentable subject matter in various technologies. Focusing ultimately on Bilski's implications for the patentability of biopharmaceutical inventions, this paper first provides a broad chron
